Lenapenem (Bo- 2727)

Class: Beta-lactam (carbapenem)

Spectrum of activity:	Gram-positive  &  Gram-negative
Details of activity:	Demonstrates high stability against DHP-1. Lenapenem performed better against MRSA than imipenem
Description:	Izumi K, Mikamo H, Kawazoe K, et al. In vitro and in vivoantibacterial activities of BO-2727 in the fields of obstetrics and Gynecology. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 137.
Institute where first reported:	Banyu; Merck and Co.
Year first mentioned:	1990
Highest developmental phase:	Phase 2
Development status:	Inactive

Chemical structure(s):
Canonical SMILES:	C[C@@H]1[C@@H]2[C@@H]([C@@H](C)O)C(=O)N2C(=C1S[C@H]3C[C@@H]([C@@H](CCNC)O)NC3)C(=O)O
Isomeric SMILES:	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)[C@@H](CCNC)O)C(=O)O)[C@@H](C)O
InChI:	InChI=1S/C18H29N3O5S/c1-8-14-13(9(2)22)17(24)21(14)15(18(25)26)16(8)27-10-6-11(20-7-10)12(23)4-5-19-3/h8-14,19-20,22-23H,4-7H2,1-3H3,(H,25,26)/t8-,9-,10+,11+,12-,13-,14-/m1/s1
InChI Key:	PZLOCBSBEUDCPF-YJIVIRPOSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/216262

External links:
Guide to Pharmacology:	lenapenem
Citation:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162678/pdf/391030.pdf